RenovoRx Inc.
Last updated September 27, 2026
Organization details
- Legal name
- RenovoRx Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- RNXT
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001574094
Board of directors
-
David Diamond · DirectorSince 2023
-
K. Angela Macfarlane · DirectorSince 2023
-
Laurence Marton · DirectorSince 2023
-
Ramtin Agah · Director · Chief Medical OfficerSince 2023
-
Robert J. Spiegel · DirectorSince 2023
-
Shaun Bagai · Director · Chief Executive OfficerSince 2023
-
Una S. Ryan · DirectorSince 2023
Chief executives
Shaun Bagai
· CEO
Dates unknown
Board connections
2 of this board's directors also sit on 3 other boards.
- via Robert J. Spiegel
- via Robert J. Spiegel
- via Una S. Ryan
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $84,494
- 13 purchases by 4 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 19, 2026 | VOLL MARK Officer (Chief Financial Officer) | Open-market purchase | +25,000 | $0.79 | $19,750 |
| Apr 3, 2026 | VOLL MARK Officer (Chief Financial Officer) | Grant or award | +80,000 | — | — |
| Mar 25, 2026 | VOLL MARK Officer (Chief Financial Officer) | Grant or award | +12,380 | — | — |
| Mar 20, 2026 | Laurence Marton Director | Open-market purchase | +9,720 | — | — |
| Mar 20, 2026 | Shaun Bagai Director, Officer (Chief Executive Officer) | Open-market purchase | +24,300 | — | — |
| Mar 20, 2026 | VOLL MARK Officer (Chief Financial Officer) | Open-market purchase | +97,200 | — | — |
| Jan 21, 2026 | Ramtin Agah Director, Officer (Chief Medical Officer) | Open-market purchase | +10,000 | $1.00 | $10,000 |
| Dec 31, 2025 | Ramtin Agah Director, Officer (Chief Medical Officer) | Open-market purchase | +9,795 | $0.86 | $8,424 |
| Dec 30, 2025 | Ramtin Agah Director, Officer (Chief Medical Officer) | Open-market purchase | +205 | $0.83 | $170 |
| Dec 18, 2025 | Shaun Bagai Director, Officer (Chief Executive Officer) | Open-market purchase | +5,000 | $0.90 | $4,500 |
| Dec 17, 2025 | Shaun Bagai Director, Officer (Chief Executive Officer) | Open-market purchase | +5,000 | $0.85 | $4,250 |
| Dec 16, 2025 | Ramtin Agah Director, Officer (Chief Medical Officer) | Open-market purchase | +12,000 | $0.85 | $10,200 |
| Dec 5, 2025 | Ramtin Agah Director, Officer (Chief Medical Officer) | Open-market purchase | +10,000 | $0.96 | $9,600 |
| Nov 24, 2025 | Ramtin Agah Director, Officer (Chief Medical Officer) | Open-market purchase | +12,000 | $0.80 | $9,600 |
| Nov 21, 2025 | Ramtin Agah Director, Officer (Chief Medical Officer) | Open-market purchase | +10,000 | $0.80 | $8,000 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.